3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Conditions
Melanoma
13
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Neoplasm Metastasis
5
Neoplasms
4
Lung Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
2
Skin Neoplasms
2
Skin Diseases
2
Pancreatic Neoplasms
2
Hematologic Neoplasms
2
Uveal Melanoma
1
Spinocerebellar Degenerations
1
Solid Tumors Harboring a BRAF V600 Mutation
1
Soft Tissue Neoplasms
1
Peripheral Nervous System Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Noonan Syndrome 5
1
Neurofibromatosis 1
1
Neurofibromatoses
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Multiple Myeloma
1
Lymphoma
1
Lymphatic Metastasis
1
Low-grade Serous Ovarian Cancer
1
Leukemia, Myeloid, Acute
1
Hereditary Sensory and Autonomic Neuropathies
1
Gliosarcoma
1
Interventions
binimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Noonan Syndrome 5
×
binimetinib
×
Clear all
NCT01885195
2021-02-21
SIGNATURE
Pfizer
Phase 2
Completed
110 enrolled
18 charts